Additional Wegovy Benefits for Heart Attack & Stroke Patients

At Diet UK, the doctors are committed to providing evidence-based, specialist treatments to individual health needs. With the latest approval of new licences for Wegovy (semaglutide), we can now offer patients who have experienced a heart attack or stroke, treatment with Wegovy, which has been demonstrated to reduce the risk of further cardiovascular events. This advancement ensures that patients who previously had limited options for medically-assisted weight loss can now access this treatment to improve both metabolic and cardiovascular health.

Wegovy, a once-weekly GLP-1 receptor agonist, has already demonstrated significant benefits in weight management and metabolic health. Now, research has confirmed that it offers cardiovascular protection, making it a crucial treatment option for those at increased risk of heart disease. Clinical trials have shown that Wegovy can reduce the risk of future heart attacks and strokes by 20%, making it a valuable addition to comprehensive cardiac care.

For patients recovering from a heart attack or stroke, weight management plays a vital role in reducing further risk factors such as high blood pressure, high cholesterol, and type 2 diabetes. Excess weight can put additional strain on the heart, increasing the likelihood of recurrent cardiovascular events. A structured approach to weight loss, with the assistance of medications like Wegovy, has been shown to help individuals achieve sustainable results, leading to better overall heart function and vascular health.

Beyond weight reduction, Wegovy also improves insulin sensitivity and reduces systemic inflammation, both of which are critical for preventing further complications in patients with a history of heart disease. Studies indicate that reducing body weight by just 5-10% can significantly lower the risk of future cardiac events, making medically-assisted weight loss a key component of long-term cardiovascular care.

Wegovy is now available for patients who:

• Have previously suffered a heart attack, stroke, or other cardiovascular event
• Have a BMI of 27 or higher with an associated health condition such as high blood pressure or type 2 diabetes.
• Are under the care of a cardiologist for ongoing cardiovascular risk management.
• Struggle with weight-related health issues that contribute to overall heart disease risk and require medically supervised intervention.

At Diet UK, we provide clinically supervised weight management programs that integrate medical treatment, nutritional support, and lifestyle coaching. Our specialist team will work with you to develop a personalised plan that aligns with your overall health goals. Our tailored approach ensures that patients not only lose weight but also adopt long-term habits that promote cardiovascular health.

Through continuous monitoring, expert guidance, and evidence-based strategies, we help patients achieve meaningful health improvements while minimising the risks associated with obesity and cardiovascular disease. By incorporating Wegovy into a comprehensive care plan, patients can experience sustainable weight loss while simultaneously reducing the likelihood of further cardiac complications.